Lion Biotechnologies (LBIO) PT Lowered to $11 at Jefferies Following 4Q

March 8, 2017 7:25 AM EST Send to a Friend
Jefferies lowered its price target on Lion Biotechnologies (NASDAQ: LBIO) to $11.00 (from $13.00) while maintaining a Buy rating. LBIO ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login